Brian Baranick, EVP, GM, Precision Oncology at EXACT SCIENCES CORP (EXAS), sold 929 shares at $70.00 ($65K) on 2024-10-08, disclosed to the SEC on 2024-10-09.
Scheduled sale ($65k) by EVP, GM, Precision Oncology under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EXAS | SELL | 2024-05-02 | $7K | — | Filing → |
| EXAS | SELL | 2024-04-03 | $147K | — | Filing → |
| EXAS | SELL | 2024-03-04 | $276K | — | Filing → |